ICMR signs agreements for first-in-human clinical trials of four new molecules ICMR partners with industry leaders for trials on molecules targeting multiple myeloma, Zika, influenza, and chronic lymphocytic…
Is India catching up with the US in accessibility to novel drugs for lymphoma? In view of a strong pharmaceutical industry support in India, the generics and biosimilars have substantially penetrated into the…
